Multi-omics test of ovarian cancer about the mechanism and early diagnosis and its chemotherapeutic sensitivity analysis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045539

Enrollment

Unknown

Registered

2021-04-19

Start date

2021-04-10

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

ovarian cancer, benign ovarian disease and normal ovary:Nil

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1.Patients who need to remove their ovaries due to various diseases; 2.Patients who agree to participate in this study.

Exclusion criteria

Exclusion criteria: 1.Those with pregnancy-related diseases; 2.Postoperative pathological findings are derived from endometrial, trophoblastic tumor, fallopian tube malignant tumor or cervical malignant tumor; 3.Infectious diseases, such as tuberculosis, pelvic inflammatory disease or pelvic abscess.

Design outcomes

Primary

Measure	Time frame
deoxyribonucleic acid, DNA;ribonucleic acid, RNA;protein;deoxyribonucleic acid, DNA;	—

Countries

China

Contacts

Public ContactLi Qiling

The First Affiliated Hospital of Xi'an Jiaotong University

liqiling@mail.xjtu.edu.cn+86 18991232838

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026